JPRN-UMIN000044830已完成未知
Retrospective Cohort Study of immune checkpoint inhibitor - Retrospective Cohort Study of immune checkpoint inhibitor
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 700
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who are judged as being inappropriate for this study by their medical doctor
研究者
相似试验
已完成
不适用
A prospective observational study of immune-checkpoint inhibitor (Nivolumab) treatment in patients with non-small cell lung canceron-small cell lung cancerJPRN-UMIN000021600Kitasato University School of Medicine52
已完成
不适用
An exploratory biomarker study of immunecheckpoint inhibitors using tumor tissue and peripheral bloodlung cancer, and melanomaJPRN-UMIN000024414Wakayama Medical University120
招募中
不适用
Cohort study of immune-checkpoint-inhibitor antibody treatment in non-small-cell lung cancernon-small-cell lung cancerJPRN-UMIN000020719Saitama Medical University International Medical Center100
已完成
不适用
A prospective observational study of immune-related adverse events, treatment efficacy, and pre-existing autoantibodies in patients with small-cell lung cancer who was treated by immune checkpoint inhibitorPatients with small cell lung cancer who was treated by chemotherapy plus immune checkpoint inhibitor as first line therapyJPRN-UMIN000042962Kobe City Medical Center General Hospital Respiratory Medicine54
进行中（未招募）
2 期
A study to investigate if atezolizumab can reduce the size of urothelial cancer before surgery and to determine how the drug worksCancerISRCTN22771691Queen Mary University of London58